EverQuote Reports Strong Q4 & Full Year 2025 Results, Initiates $50M Share Repurchase Program
summarizeSummary
EverQuote reported strong Q4 and full year 2025 financial results, including significant revenue and Adjusted EBITDA growth, and announced a new $50.0 million share repurchase program while providing a positive Q1 2026 outlook.
check_boxKey Events
-
Record Revenue Growth
Total revenue grew 32% year-over-year to $195.3 million in Q4 2025 and 38% to $692.5 million for the full year 2025.
-
Strong Profitability & Cash Flow
Adjusted EBITDA increased 32% to $25.1 million in Q4 2025 and 62% to $94.6 million for the full year. Operating cash flow reached $95.4 million for 2025.
-
$50 Million Share Repurchase Program
The company implemented an inaugural $50.0 million share repurchase program, demonstrating confidence in its valuation and future prospects, especially with the stock trading near its 52-week low.
-
Positive Q1 2026 Outlook
EverQuote provided Q1 2026 guidance with expected revenue between $175.0 - $185.0 million and Adjusted EBITDA between $23.5 - $26.5 million.
auto_awesomeAnalysis
EverQuote, Inc. announced robust financial performance for Q4 and full year 2025, significantly exceeding prior year results across key metrics. The company reported substantial revenue growth, strong Adjusted EBITDA, and healthy operating cash flow. Notably, the board authorized an inaugural $50.0 million share repurchase program, signaling strong management confidence, especially as the stock is currently trading near its 52-week low. While GAAP net income saw a significant increase, it included a one-time deferred tax benefit of $38.4 million. The positive Q1 2026 outlook further reinforces a strong operational trajectory, indicating continued growth and profitability. This combination of strong results, a significant capital allocation decision, and strategic focus on AI positions the company favorably.
At the time of this filing, EVER was trading at $14.00 on NASDAQ in the Technology sector, with a market capitalization of approximately $550.8M. The 52-week trading range was $13.93 to $30.03. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.